Claim Details
View detailed information about this claim and its related sources.
Claim Information
Complete details about this extracted claim.
- Claim Text
-
This arrangement has allowed pharmaceutical companies to move profits out of Ireland and book them in tax havens like Bermuda or the Cayman Islands, which impose no income taxes at all, and where companies have no actual business activity.
- Simplified Text
-
Licensing arrangements allow pharmaceutical companies to move profits out of Ireland to tax havens like Bermuda or the Cayman Islands.
- Confidence Score
- 0.900
- Claim Maker
- The author
- Context Type
- News Article
- Context Details
-
{ "topic": "Pharma Tariffs", "location": "Ireland, Bermuda, Cayman Islands", "source_type": "News Article" } - UUID
- 9fdae144-1ef8-43fb-b4ba-5af2ffd9d0d3
- Vector Index
- ✗ No vector
- Created
- September 11, 2025 at 8:58 PM (2 days ago)
- Last Updated
- September 11, 2025 at 8:58 PM (2 days ago)
Original Sources for this Claim (1)
All source submissions that originally contained this claim.
53
claims
🔥
2 days ago
https://www.nytimes.com/2025/08/14/health/pharma-tariffs-ireland-taxes.html
US drugmakers using Ireland for tax advantages face billions in tariffs on European medicines. Shifting production to the US increases costs. The situation highlights tax strategies and their impact.
Similar Claims (0)
Other claims identified as semantically similar to this one.
No similar claims found
This claim appears to be unique in the system.